Effects of Remote Ischemic Conditioning on Postoperative Recovery After Hepatectomy: A Randomised Controlled Trial

医学 肝切除术 围手术期 丙氨酸转氨酶 天冬氨酸转氨酶 随机对照试验 肝功能 内科学 胃肠病学 缺血 缺血预处理 外科 麻醉 切除术 碱性磷酸酶 化学 生物化学
作者
Chun Tian,Hongni Tian,Wenlang Li,Jie Chen,Qiao Guo,Guangyou Duan,He Huang
出处
期刊:Liver International [Wiley]
卷期号:45 (3): e70041-e70041 被引量:4
标识
DOI:10.1111/liv.70041
摘要

ABSTRACT Background and Aims Remote ischemic conditioning (RIC) has shown promise in preclinical and clinical studies, but its effectiveness in reducing hepatic ischemia–reperfusion injuries (HIRIs) and enhancing postoperative recovery after hepatectomy remains uncertain. In this study, we aimed to evaluate the impact of perioperative RIC (PRIC) on postoperative recovery in patients undergoing hepatectomy. Methods A randomised controlled trial was performed. A total of 135 eligible patients were randomised to either a control group (sham RIC), a PRIC‐1 group (RIC once daily for 3 days starting on the day of surgery) or a PRIC‐2 group (RIC twice daily). The primary outcome was the time to 2 times the upper limit of normal (2ULN) alanine transaminase (ALT) levels post‐hepatectomy. Secondary outcomes included time to reach 2ULN for aspartate transaminase (AST) levels, the area under the concentration–time curve on postoperative Day 7 (AUC‐POD7) for ALT, AST, total bilirubin and lactic acid, as well as assessments of gastrointestinal function and postoperative complications. Results Median time to 2ULN ALT was shorter in the PRIC‐1 and PRIC‐2 groups than in the control group (PRIC‐1: 5.0 [3.5, 6.0] vs. control: 7.0 [7.0, 10.0] days, p < 0.001; PRIC‐2: 5.0 [4.0, 8.0] vs. control: 7.0 [7.0, 10.0] days, p < 0.001). The AUC‐POD7 for ALT and AST, time to 2ULN AST, time to gastrointestinal tolerance and postoperative complications were significantly improved in the PRIC groups compared with thecontrols. Conclusions PRIC is safe and effective in reducing HIRIs and enhancing recovery post‐hepatectomy. Once‐daily PRIC offers similar benefits to twice‐daily PRIC. Trial Registration NCT06130436 ( ClinicalTrials.gov )

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6应助火星人采纳,获得10
刚刚
大模型应助科研通管家采纳,获得10
刚刚
科研通AI6应助科研通管家采纳,获得10
刚刚
斯文败类应助科研通管家采纳,获得10
刚刚
科研通AI6应助科研通管家采纳,获得10
刚刚
刚刚
Akim应助科研通管家采纳,获得10
刚刚
H-C应助科研通管家采纳,获得10
刚刚
柏林寒冬应助科研通管家采纳,获得10
刚刚
脑洞疼应助科研通管家采纳,获得10
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
kid1912应助乐观蚂蚁采纳,获得10
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
赘婿应助chiwawa采纳,获得10
1秒前
1秒前
不倦应助科研通管家采纳,获得10
1秒前
子车茗应助科研通管家采纳,获得30
1秒前
共享精神应助科研通管家采纳,获得10
1秒前
脑洞疼应助科研通管家采纳,获得10
1秒前
在水一方应助科研通管家采纳,获得10
1秒前
乐乐应助从容的幻波采纳,获得10
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
大个应助luoluo采纳,获得10
1秒前
终梦应助科研通管家采纳,获得10
2秒前
情怀应助科研通管家采纳,获得10
2秒前
柏林寒冬应助科研通管家采纳,获得10
2秒前
称心曼安应助科研通管家采纳,获得20
2秒前
风中冰香应助科研通管家采纳,获得20
2秒前
科研通AI6应助科研通管家采纳,获得10
2秒前
迷路雨寒应助小超人采纳,获得10
2秒前
丘比特应助科研通管家采纳,获得10
2秒前
SciGPT应助科研通管家采纳,获得10
2秒前
在水一方应助科研通管家采纳,获得10
2秒前
老阎应助科研通管家采纳,获得30
2秒前
虚幻谷秋完成签到,获得积分10
2秒前
隐形曼青应助科研通管家采纳,获得10
2秒前
naive应助科研通管家采纳,获得10
2秒前
不倦应助科研通管家采纳,获得10
2秒前
不倦应助科研通管家采纳,获得10
3秒前
key完成签到,获得积分10
3秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Fermented Coffee Market 2000
Methoden des Rechts 600
Constitutional and Administrative Law 500
PARLOC2001: The update of loss containment data for offshore pipelines 500
Critical Thinking: Tools for Taking Charge of Your Learning and Your Life 4th Edition 500
Vertebrate Palaeontology, 5th Edition 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5282573
求助须知:如何正确求助?哪些是违规求助? 4436555
关于积分的说明 13809715
捐赠科研通 4317159
什么是DOI,文献DOI怎么找? 2369613
邀请新用户注册赠送积分活动 1364999
关于科研通互助平台的介绍 1328450